Black Diamond Therapeutics, Inc. (BDTX)
2.395
-0.16
(-6.45%)
USD |
NASDAQ |
Jan 20, 16:00
2.40
0.00 (0.00%)
After-Hours: 17:23
Black Diamond Therapeutics Enterprise Value: 30.02M for Jan. 16, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Emergent BioSolutions, Inc. | 998.99M |
| Johnson & Johnson | 554.05B |
| Puma Biotechnology, Inc. | 265.56M |
| Oric Pharmaceuticals, Inc. | 896.52M |
| NovaBay Pharmaceuticals, Inc. | 1.864B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.498M |
| Total Expenses (Quarterly) | 8.498M |
| EPS Diluted (Quarterly) | -0.1493 |
| Earnings Yield | 15.15% |
| Operating Earnings Yield | 8.68% |
| Normalized Earnings Yield | 15.15 |